German chemicals, pharmaceuticals and life sciences group Merck entered a non-binding Memorandum of Understanding (MoU) with Afrigen Biologics to support the development...
Reducing greenhouse gas (GHG) emissions in the supply chain lies outside of a company’s direct control, so collaboration with suppliers and partners in the supply chain...
Merck has agreed to acquire US life sciences company Mirus Bio for $600 million (around €550 million) from Gamma Biosciences, a life sciences platform established by...
Agilent Technologies and Merck have made significant progress in their collaboration, launched in 2022, to enhance bioprocessing. The partnership integrates Process...
Merck is pouring over €300 million into a new Bioprocessing Production Centre in Daejeon, South Korea. This marks the largest investment by Merck's Life Science sector in...
mRNA-based vaccines against the coronavirus have become firmly established in medicine since the pandemic. Nevertheless, the technology is still at the beginning of its...
Merck will open a new € 20 million distribution center in São Paulo, Brazil to better serve its Life Science customers in the region. The new space, which will be...
